Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 3Recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Neoplasms 10Venous Thromboembolism 7Venous Thrombosis 3Treatment of Venous Thromboembolism in Cancer Patients 3Pulmonary Embolism 3Upper Extremity Deep Vein Thrombosis 2Thrombosis 1Recurrence 1Prevention of Venous Thromboembolism 1Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery 1Myeloproliferative Disorders 1Lung Neoplasms 1Hemorrhage 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Dalteparin 7apixaban 6Rivaroxaban 3edoxaban 2bemiparin 2Warfarin 2Tinzaparin 2Fondaparinux 2Enoxaparin 2Dabigatran 2Phenprocoumon 1Nephrectomy 1Nadroparin 1Heparin, Low-Molecular-Weight 1Heparin 1Aspirin 1Acetylcysteine 1Acenocoumarol 14-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Pulmonary Embolism × Rivaroxaban × Clear all
NCT02742623 2023-11-07

COSIMO

Bayer

Completed
528 enrolled

Neoplasms, Pulmonary Embolism, Venous Thrombosis

NCT02744092 2023-10-03

CANVAS

Alliance Foundation Trials, LLC.

Phase NA Completed
811 enrolled 19 charts
Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT01727427 2019-08-08

Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients

G. d'Annunzio University

Completed
695 enrolled

Neoplasms, Pulmonary Embolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡